155 related articles for article (PubMed ID: 31233194)
1. MPZL1 promotes tumor cell proliferation and migration via activation of Src kinase in ovarian cancer.
Chen D; Cao L; Wang X
Oncol Rep; 2019 Aug; 42(2):679-687. PubMed ID: 31233194
[TBL] [Abstract][Full Text] [Related]
2. Amplification of MPZL1/PZR promotes tumor cell migration through Src-mediated phosphorylation of cortactin in hepatocellular carcinoma.
Jia D; Jing Y; Zhang Z; Liu L; Ding J; Zhao F; Ge C; Wang Q; Chen T; Yao M; Li J; Gu J; He X
Cell Res; 2014 Feb; 24(2):204-17. PubMed ID: 24296779
[TBL] [Abstract][Full Text] [Related]
3. MPZL1 is highly expressed in advanced gallbladder carcinoma and promotes the aggressive behavior of human gallbladder carcinoma GBC‑SD cells.
Liu X; Huang J; Liu L; Liu R
Mol Med Rep; 2019 Sep; 20(3):2725-2733. PubMed ID: 31322261
[TBL] [Abstract][Full Text] [Related]
4. MPZL1 upregulation promotes tumor metastasis and correlates with unfavorable prognosis in non-small cell lung cancer.
Feng J; Ouyang H; Wang J; Pan D; Sheng L; Xu C; Lin W; Hu D; Chang C; Jia D
Carcinogenesis; 2022 Nov; 43(10):919-929. PubMed ID: 35727197
[TBL] [Abstract][Full Text] [Related]
5. LncRNA TNFRSF10A-AS1 promotes gastric cancer by directly binding to oncogenic MPZL1 and is associated with patient outcome.
Sun D; Gou H; Wang D; Li C; Li Y; Su H; Wang X; Zhang X; Yu J
Int J Biol Sci; 2022; 18(8):3156-3166. PubMed ID: 35637954
[No Abstract] [Full Text] [Related]
6. MPZL1 Promotes Lung Adenocarcinoma Progression by Enhancing Tumor Proliferation, Invasion, Migration, and Suppressing Immune Function via Transforming Growth Factor-β1.
Wang A; Fan F; Zang C; Li C; Hong H; Wang Z; Gao Y; Chen L; Yu X; Zhou C; Zhao C
Hum Gene Ther; 2023 Jun; 34(11-12):540-553. PubMed ID: 37183407
[TBL] [Abstract][Full Text] [Related]
7. PZR promotes metastasis of colorectal cancer through increasing FAK and Src phosphorylation.
Tan D; Zhang W; Tao Y; Galiya Y; Wang M
Acta Biochim Biophys Sin (Shanghai); 2019 Apr; 51(4):356-364. PubMed ID: 30877754
[TBL] [Abstract][Full Text] [Related]
8. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
[TBL] [Abstract][Full Text] [Related]
9. SOX2 enhances the migration and invasion of ovarian cancer cells via Src kinase.
Wang X; Ji X; Chen J; Yan D; Zhang Z; Wang Q; Xi X; Feng Y
PLoS One; 2014; 9(6):e99594. PubMed ID: 24937695
[TBL] [Abstract][Full Text] [Related]
10. MPZL1 suppresses the cancer stem-like properties of lung cancer through β-catenin/TCF4 signaling.
Ge Q; Zhou C; Zang C; Li C; Hong H; Wang K; Chen L; Zhu H; Wang A
Funct Integr Genomics; 2023 Sep; 23(4):304. PubMed ID: 37726580
[TBL] [Abstract][Full Text] [Related]
11. TEX19 promotes ovarian carcinoma progression and is a potential target for epitope vaccine immunotherapy.
Xu Z; Tang H; Zhang T; Sun M; Han Q; Xu J; Wei M; Yu Z
Life Sci; 2020 Jan; 241():117171. PubMed ID: 31843525
[TBL] [Abstract][Full Text] [Related]
12. PDZ and LIM domain protein 4 suppresses the growth and invasion of ovarian cancer cells via inactivation of STAT3 signaling.
Jia Y; Shi H; Cao Y; Feng W; Li M; Li X
Life Sci; 2019 Sep; 233():116715. PubMed ID: 31376371
[TBL] [Abstract][Full Text] [Related]
13. Sex-determining region Y-box3 (SOX3) functions as an oncogene in promoting epithelial ovarian cancer by targeting Src kinase.
Yan Q; Wang F; Miao Y; Wu X; Bai M; Xi X; Feng Y
Tumour Biol; 2016 Sep; 37(9):12263-12271. PubMed ID: 27251670
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851
[TBL] [Abstract][Full Text] [Related]
15. CKAP2 Promotes Ovarian Cancer Proliferation and Tumorigenesis Through the FAK-ERK Pathway.
Zhang M; Zhao L
DNA Cell Biol; 2017 Nov; 36(11):983-990. PubMed ID: 28933561
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of glypican-3 expression increases migration, invasion, and tumorigenicity of human ovarian cancer cells.
Liu Y; Zheng D; Liu M; Bai J; Zhou X; Gong B; Lü J; Zhang Y; Huang H; Luo W; Huang G
Tumour Biol; 2015 Sep; 36(10):7997-8006. PubMed ID: 25967456
[TBL] [Abstract][Full Text] [Related]
17. TRIB1 promotes colorectal cancer cell migration and invasion through activation MMP-2 via FAK/Src and ERK pathways.
Wang Y; Wu N; Pang B; Tong D; Sun D; Sun H; Zhang C; Sun W; Meng X; Bai J; Chen F; Geng J; Fu S; Jin Y
Oncotarget; 2017 Jul; 8(29):47931-47942. PubMed ID: 28624785
[TBL] [Abstract][Full Text] [Related]
18. HGF-independent regulation of MET and GAB1 by nonreceptor tyrosine kinase FER potentiates metastasis in ovarian cancer.
Fan G; Zhang S; Gao Y; Greer PA; Tonks NK
Genes Dev; 2016 Jul; 30(13):1542-57. PubMed ID: 27401557
[TBL] [Abstract][Full Text] [Related]
19. TIMM50 promotes tumor progression via ERK signaling and predicts poor prognosis of non-small cell lung cancer patients.
Zhang X; Han S; Zhou H; Cai L; Li J; Liu N; Liu Y; Wang L; Fan C; Li A; Miao Y
Mol Carcinog; 2019 May; 58(5):767-776. PubMed ID: 30604908
[TBL] [Abstract][Full Text] [Related]
20. Cystathionine‑γ‑lyase promotes the metastasis of breast cancer via the VEGF signaling pathway.
Wang L; Shi H; Liu Y; Zhang W; Duan X; Li M; Shi X; Wang T
Int J Oncol; 2019 Aug; 55(2):473-487. PubMed ID: 31173185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
